カテゴリー： Market Monitor Global, 世界, 医療/バイオ

おたふく風邪ワクチンの世界市場見通し2023年-2029年

◆英語タイトル：Mumps Vaccine Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5787）◆商品コード：MMG23JU5787
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：125
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Mumps Vaccine Market 調査レポートは次の情報を含め、グローバルにおけるのおたふく風邪ワクチン市場規模と予測を収録しています。・世界のおたふく風邪ワクチン市場：売上、2018年-2023年、2024年-2029年
・世界のおたふく風邪ワクチン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のおたふく風邪ワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「子供」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

おたふく風邪ワクチンのグローバル主要企業は、MedImmune、 Johnson & Johnson、 Merck & Co., Inc.、 Sanofi、 Serum Institute of India、 Bavarian Nordic、 Astellas Pharma India、 CSL Limited、 Emergent BioSolutions、 GlaxoSmithKline、 Panacea Biotec, Ltd.、 Biological E Limited、 Bharat Biotech Ltd.、 Novavax, Inc.、 Novartis、 Sinovac Biotech, Ltd.、 Incepta Vaccine Limited、 Valneva SE、 VBI Vaccines、 PT Bio Farmaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、おたふく風邪ワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のおたふく風邪ワクチン市場：タイプ別、2018年-2023年、2024年-2029年
世界のおたふく風邪ワクチン市場：タイプ別市場シェア、2022年
・子供、大人

世界のおたふく風邪ワクチン市場：用途別、2018年-2023年、2024年-2029年
世界のおたふく風邪ワクチン市場：用途別市場シェア、2022年
・病院薬局、小売薬局

世界のおたふく風邪ワクチン市場：地域・国別、2018年-2023年、2024年-2029年
世界のおたふく風邪ワクチン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるおたふく風邪ワクチンのグローバル売上、2018年-2023年
・主要企業におけるおたふく風邪ワクチンのグローバル売上シェア、2022年
・主要企業におけるおたふく風邪ワクチンのグローバル販売量、2018年-2023年
・主要企業におけるおたふく風邪ワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
MedImmune、 Johnson & Johnson、 Merck & Co., Inc.、 Sanofi、 Serum Institute of India、 Bavarian Nordic、 Astellas Pharma India、 CSL Limited、 Emergent BioSolutions、 GlaxoSmithKline、 Panacea Biotec, Ltd.、 Biological E Limited、 Bharat Biotech Ltd.、 Novavax, Inc.、 Novartis、 Sinovac Biotech, Ltd.、 Incepta Vaccine Limited、 Valneva SE、 VBI Vaccines、 PT Bio Farma

*************************************************************

・調査・分析レポートの概要
おたふく風邪ワクチン市場の定義
市場セグメント
世界のおたふく風邪ワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のおたふく風邪ワクチン市場規模
世界のおたふく風邪ワクチン市場規模：2022年 VS 2029年
世界のおたふく風邪ワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのおたふく風邪ワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のおたふく風邪ワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：子供、大人
おたふく風邪ワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院薬局、小売薬局
おたふく風邪ワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別おたふく風邪ワクチン市場規模 2022年と2029年
地域別おたふく風邪ワクチン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
MedImmune、 Johnson & Johnson、 Merck & Co., Inc.、 Sanofi、 Serum Institute of India、 Bavarian Nordic、 Astellas Pharma India、 CSL Limited、 Emergent BioSolutions、 GlaxoSmithKline、 Panacea Biotec, Ltd.、 Biological E Limited、 Bharat Biotech Ltd.、 Novavax, Inc.、 Novartis、 Sinovac Biotech, Ltd.、 Incepta Vaccine Limited、 Valneva SE、 VBI Vaccines、 PT Bio Farma
...

The MMR vaccine is a vaccine against measles, mumps, and rubella (German measles). The first dose is generally given to children around 9 months to 15 months of age, with a second dose at 15 months to 6 years of age, with at least 4 weeks between the doses.
This report aims to provide a comprehensive presentation of the global market for Mumps Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mumps Vaccine. This report contains market size and forecasts of Mumps Vaccine in global, including the following market information:
Global Mumps Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Mumps Vaccine Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Mumps Vaccine companies in 2022 (%)
The global Mumps Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Child Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Mumps Vaccine include MedImmune, Johnson & Johnson, Merck & Co., Inc., Sanofi, Serum Institute of India, Bavarian Nordic, Astellas Pharma India, CSL Limited and Emergent BioSolutions, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Mumps Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Mumps Vaccine Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Mumps Vaccine Market Segment Percentages, by Type, 2022 (%)
Child
Adult
Global Mumps Vaccine Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Mumps Vaccine Market Segment Percentages, by Application, 2022 (%)
Hospitals Pharmacies
Retail Pharmacies
Global Mumps Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Mumps Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Mumps Vaccine revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Mumps Vaccine revenues share in global market, 2022 (%)
Key companies Mumps Vaccine sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Mumps Vaccine sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
MedImmune
Johnson & Johnson
Merck & Co., Inc.
Sanofi
Serum Institute of India
Bavarian Nordic
Astellas Pharma India
CSL Limited
Emergent BioSolutions
GlaxoSmithKline
Panacea Biotec, Ltd.
Biological E Limited
Bharat Biotech Ltd.
Novavax, Inc.
Novartis
Sinovac Biotech, Ltd.
Incepta Vaccine Limited
Valneva SE
VBI Vaccines
PT Bio Farma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Mumps Vaccine, market overview.
Chapter 2: Global Mumps Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Mumps Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Mumps Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Mumps Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Mumps Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Mumps Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Mumps Vaccine Overall Market Size
2.1 Global Mumps Vaccine Market Size: 2022 VS 2029
2.2 Global Mumps Vaccine Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Mumps Vaccine Sales: 2018-2029
3 Company Landscape
3.1 Top Mumps Vaccine Players in Global Market
3.2 Top Global Mumps Vaccine Companies Ranked by Revenue
3.3 Global Mumps Vaccine Revenue by Companies
3.4 Global Mumps Vaccine Sales by Companies
3.5 Global Mumps Vaccine Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Mumps Vaccine Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Mumps Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Mumps Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Mumps Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Mumps Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Mumps Vaccine Market Size Markets, 2022 & 2029
4.1.2 Child
4.1.3 Adult
4.2 By Type – Global Mumps Vaccine Revenue & Forecasts
4.2.1 By Type – Global Mumps Vaccine Revenue, 2018-2023
4.2.2 By Type – Global Mumps Vaccine Revenue, 2024-2029
4.2.3 By Type – Global Mumps Vaccine Revenue Market Share, 2018-2029
4.3 By Type – Global Mumps Vaccine Sales & Forecasts
4.3.1 By Type – Global Mumps Vaccine Sales, 2018-2023
4.3.2 By Type – Global Mumps Vaccine Sales, 2024-2029
4.3.3 By Type – Global Mumps Vaccine Sales Market Share, 2018-2029
4.4 By Type – Global Mumps Vaccine Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Mumps Vaccine Market Size, 2022 & 2029
5.1.2 Hospitals Pharmacies
5.1.3 Retail Pharmacies
5.2 By Application – Global Mumps Vaccine Revenue & Forecasts
5.2.1 By Application – Global Mumps Vaccine Revenue, 2018-2023
5.2.2 By Application – Global Mumps Vaccine Revenue, 2024-2029
5.2.3 By Application – Global Mumps Vaccine Revenue Market Share, 2018-2029
5.3 By Application – Global Mumps Vaccine Sales & Forecasts
5.3.1 By Application – Global Mumps Vaccine Sales, 2018-2023
5.3.2 By Application – Global Mumps Vaccine Sales, 2024-2029
5.3.3 By Application – Global Mumps Vaccine Sales Market Share, 2018-2029
5.4 By Application – Global Mumps Vaccine Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Mumps Vaccine Market Size, 2022 & 2029
6.2 By Region – Global Mumps Vaccine Revenue & Forecasts
6.2.1 By Region – Global Mumps Vaccine Revenue, 2018-2023
6.2.2 By Region – Global Mumps Vaccine Revenue, 2024-2029
6.2.3 By Region – Global Mumps Vaccine Revenue Market Share, 2018-2029
6.3 By Region – Global Mumps Vaccine Sales & Forecasts
6.3.1 By Region – Global Mumps Vaccine Sales, 2018-2023
6.3.2 By Region – Global Mumps Vaccine Sales, 2024-2029
6.3.3 By Region – Global Mumps Vaccine Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Mumps Vaccine Revenue, 2018-2029
6.4.2 By Country – North America Mumps Vaccine Sales, 2018-2029
6.4.3 US Mumps Vaccine Market Size, 2018-2029
6.4.4 Canada Mumps Vaccine Market Size, 2018-2029
6.4.5 Mexico Mumps Vaccine Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Mumps Vaccine Revenue, 2018-2029
6.5.2 By Country – Europe Mumps Vaccine Sales, 2018-2029
6.5.3 Germany Mumps Vaccine Market Size, 2018-2029
6.5.4 France Mumps Vaccine Market Size, 2018-2029
6.5.5 U.K. Mumps Vaccine Market Size, 2018-2029
6.5.6 Italy Mumps Vaccine Market Size, 2018-2029
6.5.7 Russia Mumps Vaccine Market Size, 2018-2029
6.5.8 Nordic Countries Mumps Vaccine Market Size, 2018-2029
6.5.9 Benelux Mumps Vaccine Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Mumps Vaccine Revenue, 2018-2029
6.6.2 By Region – Asia Mumps Vaccine Sales, 2018-2029
6.6.3 China Mumps Vaccine Market Size, 2018-2029
6.6.4 Japan Mumps Vaccine Market Size, 2018-2029
6.6.5 South Korea Mumps Vaccine Market Size, 2018-2029
6.6.6 Southeast Asia Mumps Vaccine Market Size, 2018-2029
6.6.7 India Mumps Vaccine Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Mumps Vaccine Revenue, 2018-2029
6.7.2 By Country – South America Mumps Vaccine Sales, 2018-2029
6.7.3 Brazil Mumps Vaccine Market Size, 2018-2029
6.7.4 Argentina Mumps Vaccine Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Mumps Vaccine Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Mumps Vaccine Sales, 2018-2029
6.8.3 Turkey Mumps Vaccine Market Size, 2018-2029
6.8.4 Israel Mumps Vaccine Market Size, 2018-2029
6.8.5 Saudi Arabia Mumps Vaccine Market Size, 2018-2029
6.8.6 UAE Mumps Vaccine Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 MedImmune
7.1.1 MedImmune Company Summary
7.1.2 MedImmune Business Overview
7.1.3 MedImmune Mumps Vaccine Major Product Offerings
7.1.4 MedImmune Mumps Vaccine Sales and Revenue in Global (2018-2023)
7.1.5 MedImmune Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Mumps Vaccine Major Product Offerings
7.2.4 Johnson & Johnson Mumps Vaccine Sales and Revenue in Global (2018-2023)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 Merck & Co., Inc.
7.3.1 Merck & Co., Inc. Company Summary
7.3.2 Merck & Co., Inc. Business Overview
7.3.3 Merck & Co., Inc. Mumps Vaccine Major Product Offerings
7.3.4 Merck & Co., Inc. Mumps Vaccine Sales and Revenue in Global (2018-2023)
7.3.5 Merck & Co., Inc. Key News & Latest Developments
7.4 Sanofi
7.4.1 Sanofi Company Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Mumps Vaccine Major Product Offerings
7.4.4 Sanofi Mumps Vaccine Sales and Revenue in Global (2018-2023)
7.4.5 Sanofi Key News & Latest Developments
7.5 Serum Institute of India
7.5.1 Serum Institute of India Company Summary
7.5.2 Serum Institute of India Business Overview
7.5.3 Serum Institute of India Mumps Vaccine Major Product Offerings
7.5.4 Serum Institute of India Mumps Vaccine Sales and Revenue in Global (2018-2023)
7.5.5 Serum Institute of India Key News & Latest Developments
7.6 Bavarian Nordic
7.6.1 Bavarian Nordic Company Summary
7.6.2 Bavarian Nordic Business Overview
7.6.3 Bavarian Nordic Mumps Vaccine Major Product Offerings
7.6.4 Bavarian Nordic Mumps Vaccine Sales and Revenue in Global (2018-2023)
7.6.5 Bavarian Nordic Key News & Latest Developments
7.7 Astellas Pharma India
7.7.1 Astellas Pharma India Company Summary
7.7.2 Astellas Pharma India Business Overview
7.7.3 Astellas Pharma India Mumps Vaccine Major Product Offerings
7.7.4 Astellas Pharma India Mumps Vaccine Sales and Revenue in Global (2018-2023)
7.7.5 Astellas Pharma India Key News & Latest Developments
7.8 CSL Limited
7.8.1 CSL Limited Company Summary
7.8.2 CSL Limited Business Overview
7.8.3 CSL Limited Mumps Vaccine Major Product Offerings
7.8.4 CSL Limited Mumps Vaccine Sales and Revenue in Global (2018-2023)
7.8.5 CSL Limited Key News & Latest Developments
7.9 Emergent BioSolutions
7.9.1 Emergent BioSolutions Company Summary
7.9.2 Emergent BioSolutions Business Overview
7.9.3 Emergent BioSolutions Mumps Vaccine Major Product Offerings
7.9.4 Emergent BioSolutions Mumps Vaccine Sales and Revenue in Global (2018-2023)
7.9.5 Emergent BioSolutions Key News & Latest Developments
7.10 GlaxoSmithKline
7.10.1 GlaxoSmithKline Company Summary
7.10.2 GlaxoSmithKline Business Overview
7.10.3 GlaxoSmithKline Mumps Vaccine Major Product Offerings
7.10.4 GlaxoSmithKline Mumps Vaccine Sales and Revenue in Global (2018-2023)
7.10.5 GlaxoSmithKline Key News & Latest Developments
7.11 Panacea Biotec, Ltd.
7.11.1 Panacea Biotec, Ltd. Company Summary
7.11.2 Panacea Biotec, Ltd. Mumps Vaccine Business Overview
7.11.3 Panacea Biotec, Ltd. Mumps Vaccine Major Product Offerings
7.11.4 Panacea Biotec, Ltd. Mumps Vaccine Sales and Revenue in Global (2018-2023)
7.11.5 Panacea Biotec, Ltd. Key News & Latest Developments
7.12 Biological E Limited
7.12.1 Biological E Limited Company Summary
7.12.2 Biological E Limited Mumps Vaccine Business Overview
7.12.3 Biological E Limited Mumps Vaccine Major Product Offerings
7.12.4 Biological E Limited Mumps Vaccine Sales and Revenue in Global (2018-2023)
7.12.5 Biological E Limited Key News & Latest Developments
7.13 Bharat Biotech Ltd.
7.13.1 Bharat Biotech Ltd. Company Summary
7.13.2 Bharat Biotech Ltd. Mumps Vaccine Business Overview
7.13.3 Bharat Biotech Ltd. Mumps Vaccine Major Product Offerings
7.13.4 Bharat Biotech Ltd. Mumps Vaccine Sales and Revenue in Global (2018-2023)
7.13.5 Bharat Biotech Ltd. Key News & Latest Developments
7.14 Novavax, Inc.
7.14.1 Novavax, Inc. Company Summary
7.14.2 Novavax, Inc. Business Overview
7.14.3 Novavax, Inc. Mumps Vaccine Major Product Offerings
7.14.4 Novavax, Inc. Mumps Vaccine Sales and Revenue in Global (2018-2023)
7.14.5 Novavax, Inc. Key News & Latest Developments
7.15 Novartis
7.15.1 Novartis Company Summary
7.15.2 Novartis Business Overview
7.15.3 Novartis Mumps Vaccine Major Product Offerings
7.15.4 Novartis Mumps Vaccine Sales and Revenue in Global (2018-2023)
7.15.5 Novartis Key News & Latest Developments
7.16 Sinovac Biotech, Ltd.
7.16.1 Sinovac Biotech, Ltd. Company Summary
7.16.2 Sinovac Biotech, Ltd. Business Overview
7.16.3 Sinovac Biotech, Ltd. Mumps Vaccine Major Product Offerings
7.16.4 Sinovac Biotech, Ltd. Mumps Vaccine Sales and Revenue in Global (2018-2023)
7.16.5 Sinovac Biotech, Ltd. Key News & Latest Developments
7.17 Incepta Vaccine Limited
7.17.1 Incepta Vaccine Limited Company Summary
7.17.2 Incepta Vaccine Limited Business Overview
7.17.3 Incepta Vaccine Limited Mumps Vaccine Major Product Offerings
7.17.4 Incepta Vaccine Limited Mumps Vaccine Sales and Revenue in Global (2018-2023)
7.17.5 Incepta Vaccine Limited Key News & Latest Developments
7.18 Valneva SE
7.18.1 Valneva SE Company Summary
7.18.2 Valneva SE Business Overview
7.18.3 Valneva SE Mumps Vaccine Major Product Offerings
7.18.4 Valneva SE Mumps Vaccine Sales and Revenue in Global (2018-2023)
7.18.5 Valneva SE Key News & Latest Developments
7.19 VBI Vaccines
7.19.1 VBI Vaccines Company Summary
7.19.2 VBI Vaccines Business Overview
7.19.3 VBI Vaccines Mumps Vaccine Major Product Offerings
7.19.4 VBI Vaccines Mumps Vaccine Sales and Revenue in Global (2018-2023)
7.19.5 VBI Vaccines Key News & Latest Developments
7.20 PT Bio Farma
7.20.1 PT Bio Farma Company Summary
7.20.2 PT Bio Farma Business Overview
7.20.3 PT Bio Farma Mumps Vaccine Major Product Offerings
7.20.4 PT Bio Farma Mumps Vaccine Sales and Revenue in Global (2018-2023)
7.20.5 PT Bio Farma Key News & Latest Developments
8 Global Mumps Vaccine Production Capacity, Analysis
8.1 Global Mumps Vaccine Production Capacity, 2018-2029
8.2 Mumps Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Mumps Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Mumps Vaccine Supply Chain Analysis
10.1 Mumps Vaccine Industry Value Chain
10.2 Mumps Vaccine Upstream Market
10.3 Mumps Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Mumps Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Mumps Vaccine in Global Market
Table 2. Top Mumps Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Mumps Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Mumps Vaccine Revenue Share by Companies, 2018-2023
Table 5. Global Mumps Vaccine Sales by Companies, (K Units), 2018-2023
Table 6. Global Mumps Vaccine Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Mumps Vaccine Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Mumps Vaccine Product Type
Table 9. List of Global Tier 1 Mumps Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Mumps Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Mumps Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Mumps Vaccine Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Mumps Vaccine Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Mumps Vaccine Sales (K Units), 2018-2023
Table 15. By Type - Global Mumps Vaccine Sales (K Units), 2024-2029
Table 16. By Application – Global Mumps Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Mumps Vaccine Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Mumps Vaccine Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Mumps Vaccine Sales (K Units), 2018-2023
Table 20. By Application - Global Mumps Vaccine Sales (K Units), 2024-2029
Table 21. By Region – Global Mumps Vaccine Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Mumps Vaccine Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Mumps Vaccine Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Mumps Vaccine Sales (K Units), 2018-2023
Table 25. By Region - Global Mumps Vaccine Sales (K Units), 2024-2029
Table 26. By Country - North America Mumps Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Mumps Vaccine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Mumps Vaccine Sales, (K Units), 2018-2023
Table 29. By Country - North America Mumps Vaccine Sales, (K Units), 2024-2029
Table 30. By Country - Europe Mumps Vaccine Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Mumps Vaccine Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Mumps Vaccine Sales, (K Units), 2018-2023
Table 33. By Country - Europe Mumps Vaccine Sales, (K Units), 2024-2029
Table 34. By Region - Asia Mumps Vaccine Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Mumps Vaccine Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Mumps Vaccine Sales, (K Units), 2018-2023
Table 37. By Region - Asia Mumps Vaccine Sales, (K Units), 2024-2029
Table 38. By Country - South America Mumps Vaccine Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Mumps Vaccine Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Mumps Vaccine Sales, (K Units), 2018-2023
Table 41. By Country - South America Mumps Vaccine Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Mumps Vaccine Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Mumps Vaccine Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Mumps Vaccine Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Mumps Vaccine Sales, (K Units), 2024-2029
Table 46. MedImmune Company Summary
Table 47. MedImmune Mumps Vaccine Product Offerings
Table 48. MedImmune Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. MedImmune Key News & Latest Developments
Table 50. Johnson & Johnson Company Summary
Table 51. Johnson & Johnson Mumps Vaccine Product Offerings
Table 52. Johnson & Johnson Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Johnson & Johnson Key News & Latest Developments
Table 54. Merck & Co., Inc. Company Summary
Table 55. Merck & Co., Inc. Mumps Vaccine Product Offerings
Table 56. Merck & Co., Inc. Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Merck & Co., Inc. Key News & Latest Developments
Table 58. Sanofi Company Summary
Table 59. Sanofi Mumps Vaccine Product Offerings
Table 60. Sanofi Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Sanofi Key News & Latest Developments
Table 62. Serum Institute of India Company Summary
Table 63. Serum Institute of India Mumps Vaccine Product Offerings
Table 64. Serum Institute of India Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Serum Institute of India Key News & Latest Developments
Table 66. Bavarian Nordic Company Summary
Table 67. Bavarian Nordic Mumps Vaccine Product Offerings
Table 68. Bavarian Nordic Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Bavarian Nordic Key News & Latest Developments
Table 70. Astellas Pharma India Company Summary
Table 71. Astellas Pharma India Mumps Vaccine Product Offerings
Table 72. Astellas Pharma India Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Astellas Pharma India Key News & Latest Developments
Table 74. CSL Limited Company Summary
Table 75. CSL Limited Mumps Vaccine Product Offerings
Table 76. CSL Limited Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. CSL Limited Key News & Latest Developments
Table 78. Emergent BioSolutions Company Summary
Table 79. Emergent BioSolutions Mumps Vaccine Product Offerings
Table 80. Emergent BioSolutions Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Emergent BioSolutions Key News & Latest Developments
Table 82. GlaxoSmithKline Company Summary
Table 83. GlaxoSmithKline Mumps Vaccine Product Offerings
Table 84. GlaxoSmithKline Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. GlaxoSmithKline Key News & Latest Developments
Table 86. Panacea Biotec, Ltd. Company Summary
Table 87. Panacea Biotec, Ltd. Mumps Vaccine Product Offerings
Table 88. Panacea Biotec, Ltd. Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Panacea Biotec, Ltd. Key News & Latest Developments
Table 90. Biological E Limited Company Summary
Table 91. Biological E Limited Mumps Vaccine Product Offerings
Table 92. Biological E Limited Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Biological E Limited Key News & Latest Developments
Table 94. Bharat Biotech Ltd. Company Summary
Table 95. Bharat Biotech Ltd. Mumps Vaccine Product Offerings
Table 96. Bharat Biotech Ltd. Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Bharat Biotech Ltd. Key News & Latest Developments
Table 98. Novavax, Inc. Company Summary
Table 99. Novavax, Inc. Mumps Vaccine Product Offerings
Table 100. Novavax, Inc. Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 101. Novavax, Inc. Key News & Latest Developments
Table 102. Novartis Company Summary
Table 103. Novartis Mumps Vaccine Product Offerings
Table 104. Novartis Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 105. Novartis Key News & Latest Developments
Table 106. Sinovac Biotech, Ltd. Company Summary
Table 107. Sinovac Biotech, Ltd. Mumps Vaccine Product Offerings
Table 108. Sinovac Biotech, Ltd. Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 109. Sinovac Biotech, Ltd. Key News & Latest Developments
Table 110. Incepta Vaccine Limited Company Summary
Table 111. Incepta Vaccine Limited Mumps Vaccine Product Offerings
Table 112. Incepta Vaccine Limited Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 113. Incepta Vaccine Limited Key News & Latest Developments
Table 114. Valneva SE Company Summary
Table 115. Valneva SE Mumps Vaccine Product Offerings
Table 116. Valneva SE Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 117. Valneva SE Key News & Latest Developments
Table 118. VBI Vaccines Company Summary
Table 119. VBI Vaccines Mumps Vaccine Product Offerings
Table 120. VBI Vaccines Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 121. VBI Vaccines Key News & Latest Developments
Table 122. PT Bio Farma Company Summary
Table 123. PT Bio Farma Mumps Vaccine Product Offerings
Table 124. PT Bio Farma Mumps Vaccine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 125. PT Bio Farma Key News & Latest Developments
Table 126. Mumps Vaccine Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 127. Global Mumps Vaccine Capacity Market Share of Key Manufacturers, 2021-2023
Table 128. Global Mumps Vaccine Production by Region, 2018-2023 (K Units)
Table 129. Global Mumps Vaccine Production by Region, 2024-2029 (K Units)
Table 130. Mumps Vaccine Market Opportunities & Trends in Global Market
Table 131. Mumps Vaccine Market Drivers in Global Market
Table 132. Mumps Vaccine Market Restraints in Global Market
Table 133. Mumps Vaccine Raw Materials
Table 134. Mumps Vaccine Raw Materials Suppliers in Global Market
Table 135. Typical Mumps Vaccine Downstream
Table 136. Mumps Vaccine Downstream Clients in Global Market
Table 137. Mumps Vaccine Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Mumps Vaccine Segment by Type in 2022
Figure 2. Mumps Vaccine Segment by Application in 2022
Figure 3. Global Mumps Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Mumps Vaccine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Mumps Vaccine Revenue, 2018-2029 (US$, Mn)
Figure 7. Mumps Vaccine Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Mumps Vaccine Revenue in 2022
Figure 9. By Type - Global Mumps Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Mumps Vaccine Revenue Market Share, 2018-2029
Figure 11. By Type - Global Mumps Vaccine Sales Market Share, 2018-2029
Figure 12. By Type - Global Mumps Vaccine Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Mumps Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Mumps Vaccine Revenue Market Share, 2018-2029
Figure 15. By Application - Global Mumps Vaccine Sales Market Share, 2018-2029
Figure 16. By Application - Global Mumps Vaccine Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Mumps Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Mumps Vaccine Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Mumps Vaccine Revenue Market Share, 2018-2029
Figure 20. By Region - Global Mumps Vaccine Sales Market Share, 2018-2029
Figure 21. By Country - North America Mumps Vaccine Revenue Market Share, 2018-2029
Figure 22. By Country - North America Mumps Vaccine Sales Market Share, 2018-2029
Figure 23. US Mumps Vaccine Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Mumps Vaccine Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Mumps Vaccine Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Mumps Vaccine Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Mumps Vaccine Sales Market Share, 2018-2029
Figure 28. Germany Mumps Vaccine Revenue, (US$, Mn), 2018-2029
Figure 29. France Mumps Vaccine Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Mumps Vaccine Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Mumps Vaccine Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Mumps Vaccine Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Mumps Vaccine Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Mumps Vaccine Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Mumps Vaccine Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Mumps Vaccine Sales Market Share, 2018-2029
Figure 37. China Mumps Vaccine Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Mumps Vaccine Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Mumps Vaccine Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Mumps Vaccine Revenue, (US$, Mn), 2018-2029
Figure 41. India Mumps Vaccine Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Mumps Vaccine Revenue Market Share, 2018-2029
Figure 43. By Country - South America Mumps Vaccine Sales Market Share, 2018-2029
Figure 44. Brazil Mumps Vaccine Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Mumps Vaccine Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Mumps Vaccine Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Mumps Vaccine Sales Market Share, 2018-2029
Figure 48. Turkey Mumps Vaccine Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Mumps Vaccine Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Mumps Vaccine Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Mumps Vaccine Revenue, (US$, Mn), 2018-2029
Figure 52. Global Mumps Vaccine Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Mumps Vaccine by Region, 2022 VS 2029
Figure 54. Mumps Vaccine Industry Value Chain
Figure 55. Marketing Channels


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ おたふく風邪ワクチンの世界市場見通し2023年-2029年(Mumps Vaccine Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 麻疹・おたふく風邪・風疹ウイルスワクチンの世界市場見通し2023年-2029年
  • 麻疹ワクチンの世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆